Skip to main content
Top
Literature
1.
go back to reference Barakate MS, Stephan MS, Waugh RC et al (1999) Pyogenic liver abscess: a review of 10 years’ experience in management. Aust N Z J Surg 69(3):205–209PubMedCrossRef Barakate MS, Stephan MS, Waugh RC et al (1999) Pyogenic liver abscess: a review of 10 years’ experience in management. Aust N Z J Surg 69(3):205–209PubMedCrossRef
2.
go back to reference Chou FF, Sheen-Chen SM, Chen YS et al (1997) Single and multiple pyogenic liver abscesses: clinical course, etiology and results of treatment. World J Surg 21:384–389PubMedCrossRef Chou FF, Sheen-Chen SM, Chen YS et al (1997) Single and multiple pyogenic liver abscesses: clinical course, etiology and results of treatment. World J Surg 21:384–389PubMedCrossRef
3.
go back to reference Wang JH, Liu YC, Lee SS et al (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26:1434–1438PubMedCrossRef Wang JH, Liu YC, Lee SS et al (1998) Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26:1434–1438PubMedCrossRef
4.
go back to reference Chan KS, Yu WL, Tsai CL et al (2007) Pyogenic liver abscess caused by Klebsiella pneumoniae: analysis of the clinical characteristics and outcomes of 84 patients. Chin Med J 120(2):136–139PubMed Chan KS, Yu WL, Tsai CL et al (2007) Pyogenic liver abscess caused by Klebsiella pneumoniae: analysis of the clinical characteristics and outcomes of 84 patients. Chin Med J 120(2):136–139PubMed
Metadata
Title
Severe systemic sepsis due to pyogenic liver abscess
Authors
G. Aygencel
M. Dizbay
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2012
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-010-0611-2

Other articles of this Issue 2/2012

Irish Journal of Medical Science (1971 -) 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine